Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)
Angewandte Chemie International Edition · 15.01.2024 · 63 (3)
DOI: 10.1002/anie.202309706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 14.12.2023. Verfasst von Thomas M Geiger und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry Clemens-Schöpf-Institute, Technical University Darmstadt, Peter-Grünberg-Straße 4, 64287, Darmstadt, Germany. Hauptthemen laut MEDLINE: Proteolysis Targeting Chimera, Tacrolimus Binding Protein 1A. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Hessisches Ministerium für Wissenschaft und Kunst.
Abstract (Originalsprache)
The FK506‐binding protein 51 (FKBP51) is a promising target in a variety of disorders including depression, chronic pain, and obesity. Previous FKBP51‐targeting strategies were restricted to occupation of the FK506‐binding site, which does not affect core functions of FKBP51. Here, we report the discovery of the first FKBP51 proteolysis targeting chimera (PROTAC) that enables degradation of FKBP51 abolishing its scaffolding function. Initial synthesis of 220 FKBP‐focused PROTACs yielded a plethora of active PROTACs for FKBP12, six for FKBP51, and none for FKBP52. Structural analysis of a binary FKBP12:PROTAC complex revealed the molecular basis for negative cooperativity. Linker‐based optimization of first generation FKBP51 PROTACs led to the PROTAC SelDeg51 with improved cellular activity, selectivity, and high cooperativity. The structure of the ternary FKBP51:SelDeg51:VCB complex revealed how SelDeg51 establishes cooperativity by dimerizing FKBP51 and the von Hippel‐Lindau protein (VHL) in a glue‐like fashion. SelDeg51 efficiently depletes FKBP51 and reactivates glucocorticoid receptor (GR)‐signalling, highlighting the enhanced efficacy of full protein degradation compared to classical FKBP51 binding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry Clemens-Schöpf-Institute, Technical University Darmstadt, Peter-Grünberg-Straße 4, 64287, Darmstadt, Germany.
- Centre for Synthetic Biology, Technical University of Darmstadt, 64283, Darmstadt, Germany.
ORCID-Profile: Felix Hausch
Förderung
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Hessisches Ministerium für Wissenschaft und Kunst
- Alexander von Humboldt-Stiftung
- NCI NIH HHS
Zitieren
APA
Geiger, T. M., Walz, M., Meyners, C., Kuehn, A., Dreizler, J. K., Sugiarto, W. O., Maciel, E. V. S., Zheng, M., Lermyte, F., & Hausch, F. (2024). Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51). Angewandte Chemie International Edition, 63(3). https://doi.org/10.1002/anie.202309706
Vancouver
Geiger TM, Walz M, Meyners C, Kuehn A, Dreizler JK, Sugiarto WO, et al. Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51). Angewandte Chemie International Edition. 2024;63(3). doi:10.1002/anie.202309706
BibTeX
@article{Geiger2024,
author = {Geiger, Thomas M and Walz, Michael and Meyners, Christian and Kuehn, Angela and Dreizler, Johannes K and Sugiarto, Wisely O and Maciel, Edvaldo V S and Zheng, Min and Lermyte, Frederik and Hausch, Felix},
title = {Discovery of a Potent Proteolysis Targeting Chimera Enables Targeting the Scaffolding Functions of FK506‐Binding Protein 51 (FKBP51)},
journal = {Angewandte Chemie International Edition},
year = {2024},
volume = {63},
number = {3},
doi = {10.1002/anie.202309706}
}
EUVIMED